2018
DOI: 10.1016/j.crad.2018.04.005
|View full text |Cite
|
Sign up to set email alerts
|

Correlation of human papilloma virus status with quantitative perfusion/diffusion/metabolic imaging parameters in the oral cavity and oropharyngeal squamous cell carcinoma: comparison of primary tumour sites and metastatic lymph nodes

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

6
39
1

Year Published

2019
2019
2024
2024

Publication Types

Select...
7
1

Relationship

0
8

Authors

Journals

citations
Cited by 20 publications
(46 citation statements)
references
References 33 publications
6
39
1
Order By: Relevance
“…However, the MTV of LNs was found to be higher in the HPV-positive group than in the HPV-negative one. Our results on DCE-MRI are in line with previous investigations that did not report any difference in perfusion parameters according to HPV status, for both PTs and metastatic LNs [22,28]. While conflicting results have been reported on the association between 18 F-FDG-PET/CT parameters and HPV-status, some studies documenting SUV values of PTs have shown that these are lower in HPV-positive than in HPV-negative patients [38][39][40].…”
Section: Plos Onesupporting
confidence: 92%
See 2 more Smart Citations
“…However, the MTV of LNs was found to be higher in the HPV-positive group than in the HPV-negative one. Our results on DCE-MRI are in line with previous investigations that did not report any difference in perfusion parameters according to HPV status, for both PTs and metastatic LNs [22,28]. While conflicting results have been reported on the association between 18 F-FDG-PET/CT parameters and HPV-status, some studies documenting SUV values of PTs have shown that these are lower in HPV-positive than in HPV-negative patients [38][39][40].…”
Section: Plos Onesupporting
confidence: 92%
“…Previous studies have focused on the correlation between perfusion and metabolic imaging in HNSCC, using DCE-MRI and 18 F-FDG PET or 18 F-FMISO (fluoromisonidazole) PET [19][20][21][22][23][24][25][26][27][28], as well as with simultaneous PET/MR systems [21,23,32,36]. However, most of these studies investigated perfusion and metabolic parameters in the PT [19][20][21]23,24,26], while only a few investigations have evaluated the metastatic LNs [25,27,28], reporting conflicting results.…”
Section: Plos Onementioning
confidence: 99%
See 1 more Smart Citation
“…In the present study, differences between SUVmax or SUVmean and HPV or p16 presence were insignificant. Comparable results have been obtained in other studies, where no differences in SUVmax values between p16-and HPV-positive, and p16-and HPV-negative patients were reported [40][41][42]. By contrast, Schouten et al demonstrated that SUVmax in HPV-positive tumors was significantly lower than in HPV-negative tumors [43].…”
Section: Discussionsupporting
confidence: 51%
“…HPV-positive oropharyngeal cancers generally have more favorable prognosis than HPV-negative SCC [3]. There are certain imaging findings that may be helpful for differentiating HPV-positive SCC from the HPV-negative counterparts [4, 5]. In particular, HPV-positive SCC tend to display well-defined borders and cystic nodal metastases, while the HPV-negative tumors more commonly have poorly defined borders (Fig.…”
Section: Oral Cavity and Oropharynx Tumorsmentioning
confidence: 99%